Analysts project fiscal second quarter 2026 revenue of $10.7 billion, representing 11.5% year-over-year growth. Consensus earnings per share (EPS) stands at $3.09, implying roughly 12% growth from the prior year.
MRVL shares are declining approximately 5% in Monday's session, pulling back from a 52-week high of $170.84 reached earlier in the day toward the $164 range. The primary driver is a sector-wide AI and semiconductor selloff, with bellwether peer ARM plunging over 10% in the same session, pulling the broader chip complex lower.
DPZ shares are falling approximately 10% in Monday's session, trading near $331 from a prior close of $368.18 on April 24, 2026. The primary catalyst is a disappointing Q1 2026 earnings report, with both revenue and EPS coming in below analyst expectations.
ARM shares are declining approximately 10% in Monday's session, retreating to roughly $211.33 from a prior close of $234.81 on April 24, 2026. The primary driver is aggressive profit-taking following a near-70% price rally over just one month — from $136.96 on March 30 to $234.81 by April 24.
CMPX shares are plunging approximately 62% in Monday's session, collapsing to roughly $1.98 from a prior close of $5.21 on April 24, 2026. The primary catalyst is the presentation of topline secondary endpoint data from the Phase 2/3 COMPANION-002 trial of tovecimig (CTX-009) plus paclitaxel in advanced biliary tract cancer, widely interpreted as disappointing.
AAOI shares are declining approximately 12% in Monday's session, pulling back to roughly $142.71 from a prior close of $162.17 on April 24, 2026. The drop is primarily driven by aggressive profit-taking following Friday's 17.74% single-session surge.
POET shares are plunging approximately 42% in Monday's premarket session, falling to around $8.76 after closing at $15.10 on April 24, 2026. The selloff represents a sharp mean-reversion following a stunning 108% weekly rally driven by confirmed supply orders within Marvell Technology's AI ecosystem.
Ventas is slated to release its fiscal Q1 2026 results on April 27, 2026, after the NYSE close. Consensus expectations call for $1.66 billion in revenue (+16.6% YoY) and earnings per share (EPS) of $0.12.
Celestica Inc. ( CLS ) follows a calendar fiscal year that ends on December 31, so its first quarter of 2026 (Q1 2026) covers January‑March 2026. The company closed Q4 2025 on a strong note, posting $3.65 billion in revenue and $1.89 in adjusted EPS, and used that momentum to raise its full‑year outlook. This earnings window is critical because Celestica is positioning itself as a key supplier of AI‑related data‑center hardware – a segment that’s expanding quickly as hyperscalers increase AI workloads. Investors are therefore focused on how quickly the new capacity can be turned into commercial orders and whether margins can keep improving.
Nucor Corporation (NYSE: NUE ) is North America’s largest steel recycler and a leading vertically integrated steel producer. The upcoming first‑quarter 2026 earnings are critical because they will indicate whether the company can sustain the margin expansion seen after a robust fourth‑quarter 2025 rebound. Steel demand remains closely tied to non‑residential construction and infrastructure spending, both of which are receiving renewed policy attention. Investors also keep an eye on Nucor’s capital‑return strategy—share buybacks and dividend payouts—as a gauge of confidence in cash generation.
Analysts forecast Q1 2026 revenue of approximately $1.21 billion, a modest year‑over‑year increase. Projected earnings per share (EPS) are $2.42, reflecting continued profitability despite higher operating costs.
Cadence Design Systems ( CDNS ) leads the electronic design automation (EDA) space with a portfolio that spans software, hardware platforms, and semiconductor IP. The upcoming first‑quarter 2026 results are a critical checkpoint to see if the demand for its AI‑driven design solutions can sustain the momentum built in a record‑setting 2025. Investors are also focused on whether Cadence can keep its high‑margin mix and convert a $7.8 billion backlog into near‑term revenue growth.
Verizon Communications VZ is the largest integrated telecom provider in the United States, serving both consumer and enterprise markets with wireless, fiber‑optic broadband, and managed network services. The upcoming Q1 2026 report is the first after Verizon’s acquisition of Frontier Communications, which expands its fiber footprint to more than 30 million locations. Investors are keen to see how the company leverages its 5G network‑slice capabilities and whether the record net additions recorded in Q4 2025 can be sustained. The outcome will influence FY 2026 earnings expectations, dividend policy, and capital‑allocation priorities.
EXTR stock price climbed +15% over the last 30 days, fueled by positive signals on AI-driven cloud networking demand and anticipation ahead of quarterly earnings. The stock rose +16% over the past quarter, supported by strong prior-quarter results showing revenue growth and sequential improvement.
COHU stock surged +57% over the past 30 days, driven by analyst price target increases and strong order wins in high-performance computing (HPC) testing equipment. Over the past quarter, shares climbed +62%, reflecting recovery from an earnings miss and renewed demand in the semiconductor testing sector.
Knowles Corporation (KN) stock surged +20.3% over the past 30 days, driven primarily by a strong Q1 2026 earnings beat with revenue growth of 15.8% year-over-year (YoY). Over the past quarter, shares climbed +26.6%, supported by robust quarterly results, analyst price target increases, and positive sector rotation in technology amid geopolitical shifts.
Shares experienced a sharp decline of over 50% following interim Phase 1 data for obesity drug WVE-007, as results underwhelmed versus high expectations. Analysts retain a Strong Buy consensus with an average price target near $28, implying substantial upside potential.
XPeng reported strong March vehicle deliveries, surging 80% month-over-month, boosting shares. Shares rose around 4% recently amid talks with overseas automakers and plans for new plants abroad.
CNDT stock rose +34% over the past 30 days, driven by recognition of its undervaluation and leadership in healthcare payer operations. Over the past quarter, shares gained +1%, amid volatile trading with a dip following Q4 earnings before a partial recovery.
STNE stock declined approximately 15% over the past 30 days, primarily due to a sharp drop on the ex-dividend date following an extraordinary $2.53 per share cash dividend announcement. Over the past quarter, the stock fell around 25%, reflecting heightened volatility amid mixed market sessions and analyst adjustments.